Wednesday, March 29, 2017Akebia to Present at the 16th Annual Needham Healthcare Conference
Tuesday, March 28, 2017Akebia Announces Publication of Phase 2a Results for Vadadustat in Patients with Anemia Related to Chronic Kidney Disease
Monday, March 6, 2017Akebia Announces Fourth Quarter and Full-Year 2016 Financial Results
Wednesday, March 1, 2017Akebia to Host Conference Call on March 6th to Discuss Full-Year 2016 Financial Results and Corporate Highlights
Monday, February 13, 2017Akebia Licenses Portfolio of Novel HIF Compounds from Johnson & Johnson Innovation
Friday, February 3, 2017Akebia to Present at the 19th BIO CEO & Investor Conference
Tuesday, December 20, 2016Akebia and Otsuka Pharmaceutical Announce Collaboration to Develop and Commercialize Vadadustat in the U.S.
Monday, December 12, 2016Akebia Prevails in Additional European Patent Dispute
Friday, December 2, 2016Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Wednesday, November 9, 2016Akebia Announces Third Quarter 2016 Financial Results
Monday, October 31, 2016Akebia to Present at the Credit Suisse 25th Annual Healthcare Conference
Monday, October 17, 2016Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2016 Annual Meeting
View all press releases »
Downloadable tools, news, and press releases
© 2017 Akebia Therapeutics. All rights reserved.